119 related articles for article (PubMed ID: 19023543)
1. Cytotoxicity of amphotericin B-incorporated polymeric micelles composed of poly(DL-lactide-co-glycolide)/dextran graft copolymer.
Bang JY; Song CE; Kim C; Park WD; Cho KR; Kim PI; Lee SR; Chung WT; Choi KC
Arch Pharm Res; 2008 Nov; 31(11):1463-9. PubMed ID: 19023543
[TBL] [Abstract][Full Text] [Related]
2. Amphotericin B-incorporated polymeric micelles composed of poly(d,l-lactide-co-glycolide)/dextran graft copolymer.
Choi KC; Bang JY; Kim PI; Kim C; Song CE
Int J Pharm; 2008 May; 355(1-2):224-30. PubMed ID: 18242900
[TBL] [Abstract][Full Text] [Related]
3. Encapsulation of amphotericin B in poly(ethylene glycol)-block-poly(epsilon-caprolactone-co-trimethylenecarbonate) polymeric micelles.
Vandermeulen G; Rouxhet L; Arien A; Brewster ME; Préat V
Int J Pharm; 2006 Feb; 309(1-2):234-40. PubMed ID: 16406402
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin-incorporated polymeric micelles composed of dextran-b-poly(DL-lactide-co-glycolide) copolymer.
Jeong YI; Kim DH; Chung CW; Yoo JJ; Choi KH; Kim CH; Ha SH; Kang DH
Int J Nanomedicine; 2011; 6():1415-27. PubMed ID: 21796244
[TBL] [Abstract][Full Text] [Related]
5. Amphotericin B encapsulated in micelles based on poly(ethylene oxide)-block-poly(L-amino acid) derivatives exerts reduced in vitro hemolysis but maintains potent in vivo antifungal activity.
Adams ML; Andes DR; Kwon GS
Biomacromolecules; 2003; 4(3):750-7. PubMed ID: 12741794
[TBL] [Abstract][Full Text] [Related]
6. Mixed micellar nanoparticle of amphotericin B and poly styrene-block-poly ethylene oxide reduces nephrotoxicity but retains antifungal activity.
Han K; Miah MA; Shanmugam S; Yong CS; Choi HG; Kim JA; Yoo BK
Arch Pharm Res; 2007 Oct; 30(10):1344-9. PubMed ID: 18038914
[TBL] [Abstract][Full Text] [Related]
7. Antitumor effect of adriamycin-encapsulated nanoparticles of poly(DL-lactide-co-glycolide)-grafted dextran.
Choi KC; Bang JY; Kim C; Kim PI; Lee SR; Chung WT; Park WD; Park JS; Lee YS; Song CE; Lee HY
J Pharm Sci; 2009 Jun; 98(6):2104-12. PubMed ID: 18823029
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin release from core-shell type nanoparticles of poly(DL-lactide-co-glycolide)-grafted dextran.
Jeong YI; Choi KC; Song CE
Arch Pharm Res; 2006 Aug; 29(8):712-9. PubMed ID: 16964768
[TBL] [Abstract][Full Text] [Related]
9. Development and characterization of oral lipid-based amphotericin B formulations with enhanced drug solubility, stability and antifungal activity in rats infected with Aspergillus fumigatus or Candida albicans.
Wasan EK; Bartlett K; Gershkovich P; Sivak O; Banno B; Wong Z; Gagnon J; Gates B; Leon CG; Wasan KM
Int J Pharm; 2009 May; 372(1-2):76-84. PubMed ID: 19236839
[TBL] [Abstract][Full Text] [Related]
10. Amphotericin B aggregation inhibition with novel nanoparticles prepared with poly(epsilon-caprolactone)/poly(n,n-dimethylamino-2-ethyl methacrylate) diblock copolymer.
Shim YH; Kim YC; Lee HJ; Bougard F; Dubois P; Choi KC; Chung CW; Kang DH; Jeong YI
J Microbiol Biotechnol; 2011 Jan; 21(1):28-36. PubMed ID: 21301189
[TBL] [Abstract][Full Text] [Related]
11. Lipoamino acid-based micelles as promising delivery vehicles for monomeric amphotericin B.
Serafim C; Ferreira I; Rijo P; Pinheiro L; Faustino C; Calado A; Garcia-Rio L
Int J Pharm; 2016 Jan; 497(1-2):23-35. PubMed ID: 26617315
[TBL] [Abstract][Full Text] [Related]
12. Design of Micelle Nanocontainers Based on PDMAEMA-b-PCL-b-PDMAEMA Triblock Copolymers for the Encapsulation of Amphotericin B.
Diaz IL; Parra C; Linarez M; Perez LD
AAPS PharmSciTech; 2015 Oct; 16(5):1069-78. PubMed ID: 25669917
[TBL] [Abstract][Full Text] [Related]
13. Analytical method development and comparability study for AmBisome® and generic Amphotericin B liposomal products.
Liu Y; Mei Z; Mei L; Tang J; Yuan W; Srinivasan S; Ackermann R; Schwendeman AS
Eur J Pharm Biopharm; 2020 Dec; 157():241-249. PubMed ID: 32980448
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and toxicity evaluation of new amphotericin B micelle systems for brain fungal infections.
Moreno-Rodríguez AC; Torrado-Durán S; Molero G; García-Rodríguez JJ; Torrado-Santiago S
Int J Pharm; 2015 Oct; 494(1):17-22. PubMed ID: 26256151
[TBL] [Abstract][Full Text] [Related]
15. Water-soluble amphotericin B-polyvinylpyrrolidone complexes with maintained antifungal activity against Candida spp. and Aspergillus spp. and reduced haemolytic and cytotoxic effects.
Charvalos E; Tzatzarakis MN; Van Bambeke F; Tulkens PM; Tsatsakis AM; Tzanakakis GN; Mingeot-Leclercq MP
J Antimicrob Chemother; 2006 Feb; 57(2):236-44. PubMed ID: 16361329
[TBL] [Abstract][Full Text] [Related]
16. In vitro dissociation of antifungal efficacy and toxicity for amphotericin B-loaded poly(ethylene oxide)-block-poly(beta benzyl L aspartate) micelles.
Yu BG; Okano T; Kataoka K; Sardari S; Kwon GS
J Control Release; 1998 Dec; 56(1-3):285-91. PubMed ID: 9801451
[TBL] [Abstract][Full Text] [Related]
17. Polymeric micelles for drug delivery: solubilization and haemolytic activity of amphotericin B.
Yu BG; Okano T; Kataoka K; Kwon G
J Control Release; 1998 Apr; 53(1-3):131-6. PubMed ID: 9741920
[TBL] [Abstract][Full Text] [Related]
18. A novel performing PEG-cholane nanoformulation for Amphotericin B delivery.
Luengo-Alonso C; Torrado JJ; Ballesteros MP; Malfanti A; Bersani S; Salmaso S; Caliceti P
Int J Pharm; 2015 Nov; 495(1):41-51. PubMed ID: 26319629
[TBL] [Abstract][Full Text] [Related]
19. Development of respirable nanomicelle carriers for delivery of amphotericin B by jet nebulization.
Gilani K; Moazeni E; Ramezanli T; Amini M; Fazeli MR; Jamalifar H
J Pharm Sci; 2011 Jan; 100(1):252-9. PubMed ID: 20602350
[TBL] [Abstract][Full Text] [Related]
20. Amphotericin B/sterol co-loaded PEG-phospholipid micelles: effects of sterols on aggregation state and hemolytic activity of amphotericin B.
Diezi TA; Kwon G
Pharm Res; 2012 Jul; 29(7):1737-44. PubMed ID: 22130733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
